Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Completed 10Terminated 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Plasma cell 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 514Leukemia 340Leukemia, Lymphocytic, Chronic, B-Cell 322Precursor Cell Lymphoblastic Leukemia-Lymphoma 291Myelodysplastic Syndromes 235Lymphoma, Non-Hodgkin 173Lymphoma 162Leukemia, Myelogenous, Chronic, BCR-ABL Positive 139Hematologic Neoplasms 133Multiple Myeloma 121Lymphoma, Follicular 120Lymphoma, Large B-Cell, Diffuse 119Lymphoma, Mantle-Cell 118Recurrence 115Hodgkin Disease 99Burkitt Lymphoma 99Lymphoma, B-Cell, Marginal Zone 98Leukemia, Myelomonocytic, Chronic 78Congenital Abnormalities 78Leukemia, Myeloid, Chronic-Phase 68Neoplasms 67Myeloproliferative Disorders 66Lymphoma, Large-Cell, Immunoblastic 64Blast Crisis 59Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 57Waldenstrom Macroglobulinemia 53Primary Myelofibrosis 53Lymphoma, T-Cell, Cutaneous 52Leukemia, Myeloid, Accelerated Phase 50Neoplasms, Plasma Cell 48

Interventions

Febuxostat 1AZD0466 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Tumor Lysis Syndrome × Other hematologic neoplasm × Clear all
NCT04214093 2023-08-02

A Study of AZD0466 in Patients With Advanced Hematologic or Solid Tumors

AstraZeneca

Phase 1 Terminated
9 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Recurrence, Tumor Lysis Syndrome, Hematologic Neoplasms

NCT03605212 2021-06-03

FLORET

Menarini Group

Phase 1/2 Terminated
30 enrolled 14 charts
Other hematologic neoplasm

Tumor Lysis Syndrome, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡